Phibro Animal Health (PAHC) Shares Sold by Macquarie Group Ltd.

Macquarie Group Ltd. decreased its holdings in Phibro Animal Health (NASDAQ:PAHC) by 29.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,491 shares of the company’s stock after selling 2,300 shares during the period. Macquarie Group Ltd.’s holdings in Phibro Animal Health were worth $184,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the business. First Trust Advisors LP raised its stake in Phibro Animal Health by 14.4% in the fourth quarter. First Trust Advisors LP now owns 17,571 shares of the company’s stock valued at $589,000 after buying an additional 2,212 shares during the period. Allianz Asset Management GmbH raised its stake in Phibro Animal Health by 2.3% in the third quarter. Allianz Asset Management GmbH now owns 108,930 shares of the company’s stock valued at $4,036,000 after buying an additional 2,465 shares during the period. First Manhattan Co. bought a new stake in Phibro Animal Health in the fourth quarter valued at approximately $100,000. Russell Investments Group Ltd. raised its stake in Phibro Animal Health by 7.6% in the third quarter. Russell Investments Group Ltd. now owns 44,173 shares of the company’s stock valued at $1,636,000 after buying an additional 3,105 shares during the period. Finally, California Public Employees Retirement System raised its stake in Phibro Animal Health by 9.5% in the third quarter. California Public Employees Retirement System now owns 44,994 shares of the company’s stock valued at $1,667,000 after buying an additional 3,894 shares during the period. Hedge funds and other institutional investors own 48.08% of the company’s stock.

How to Become a New Pot Stock Millionaire

A number of equities analysts have recently weighed in on the company. Zacks Investment Research lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Wednesday, April 11th. BidaskClub upgraded Phibro Animal Health from a “strong sell” rating to a “sell” rating in a research note on Saturday, March 3rd. ValuEngine upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Wednesday, February 28th. Morgan Stanley increased their target price on Phibro Animal Health from $30.00 to $36.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 7th. Finally, Credit Suisse Group increased their target price on Phibro Animal Health from $37.00 to $39.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 6th. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $38.20.

In related news, insider Jack Bendheim sold 36,000 shares of the stock in a transaction that occurred on Thursday, March 1st. The stock was sold at an average price of $38.35, for a total transaction of $1,380,600.00. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, COO Larry Lee Miller sold 54,572 shares of the stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $35.36, for a total value of $1,929,665.92. Following the sale, the chief operating officer now directly owns 8,582 shares in the company, valued at approximately $303,459.52. The disclosure for this sale can be found here. In the last quarter, insiders have sold 276,056 shares of company stock worth $10,495,260. 51.88% of the stock is owned by corporate insiders.

Shares of NASDAQ PAHC opened at $42.60 on Tuesday. The company has a market cap of $1,694.05, a PE ratio of 28.21, a PEG ratio of 2.99 and a beta of 0.93. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.75 and a current ratio of 3.12. Phibro Animal Health has a 1-year low of $27.00 and a 1-year high of $43.15.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Monday, February 5th. The company reported $0.44 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.38 by $0.06. The company had revenue of $205.90 million for the quarter, compared to analyst estimates of $194.90 million. Phibro Animal Health had a return on equity of 40.49% and a net margin of 7.90%. The firm’s quarterly revenue was up 7.5% compared to the same quarter last year. During the same quarter last year, the company earned $0.39 earnings per share. equities research analysts predict that Phibro Animal Health will post 1.69 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 28th. Stockholders of record on Wednesday, March 7th were paid a dividend of $0.10 per share. The ex-dividend date of this dividend was Tuesday, March 6th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.94%. Phibro Animal Health’s dividend payout ratio (DPR) is currently 26.49%.

TRADEMARK VIOLATION WARNING: “Phibro Animal Health (PAHC) Shares Sold by Macquarie Group Ltd.” was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be accessed at https://www.chaffeybreeze.com/2018/04/17/phibro-animal-health-pahc-shares-sold-by-macquarie-group-ltd.html.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply